JPH08509456A - 黄体ホルモン関連の破綻出血の最小化 - Google Patents
黄体ホルモン関連の破綻出血の最小化Info
- Publication number
- JPH08509456A JPH08509456A JP5519490A JP51949093A JPH08509456A JP H08509456 A JPH08509456 A JP H08509456A JP 5519490 A JP5519490 A JP 5519490A JP 51949093 A JP51949093 A JP 51949093A JP H08509456 A JPH08509456 A JP H08509456A
- Authority
- JP
- Japan
- Prior art keywords
- administered
- antiprogestin
- luteinizing hormone
- progesterone
- org
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 抗黄体ホルモンの生物学的有効量を投与することから成る黄体ホルモン のみの製薬調剤物を常用する女性の、子宮出血を最小化する方法。 2. 抗黄体ホルモンが、プロゲステロン合成を阻害する化合物または、プロ ゲステロンリセプターの拮抗剤である請求の範囲第1項記載の方法。 3. 上記拮抗剤が、RU486,Org 33628,Org 31806及びOrg 31710から成る群 から選ばれる請求の範囲第1項記載の方法。 4. 上記黄体ホルモンが、デソゲストレルである請求の範囲第1項記載の方 法。 5. 上記黄体ホルモンと、上記抗黄体ホルモンが、同時に投与されている請 求の範囲第1項記載の方法。 6. 上記抗黄体ホルモンは、丸剤または錠剤の形で投与されている請求の範 囲第1項記載の方法。 7. 上記抗黄体ホルモンが、移植の成分として投与与されている請求の範囲 第1項記載の方法。 8. 上記拮抗剤が、約10mgから約250mgまでを1回の服用として投与されて いる請求の範囲第3項記載の方法。 9. 上記拮抗剤が、30日毎に1回投与されている請求の範囲第3項記載の 方法。 10.上記拮抗剤が、60日毎に1回投与されている請求の範囲第3項記載の 方法。 11.上記拮抗剤が、90日毎に1回投与されている請求の範囲第3項記載の 方法。 12.上記拮抗剤が、1周期28日目に投与されている請求の範囲第3項記載 の方法。 13.生物学的有効量の黄体ホルモンと抗黄体ホルモンを含有することから成 る組成物を女性に投与する、妊娠調節方法。 14.黄体ホルモンと抗黄体ホルモンを含有することから成る避妊薬組成物。 15.上記黄体ホルモンがデソゲストレルである請求の範囲第14項記載の組 成物。 16.上記抗黄体ホルモンが、RU486,Org 33628,Org 31710及びOrg 31806か ら成る群から選ばれている請求の範囲第14項記載の組成物。 17.上記黄体ホルモンが、デソゲストレルであり、上記抗黄体ホルモンは、 Org 31710である請求の範囲第14項記載の組成物。 18.基質、黄体ホルモン及び抗黄体ホルモンとして機能する、製薬的に容認 できる不活性な核物質を含有することから成る、皮下又は局所投与を意図した移 植片。 19.一日ごとに一回連続的に投与されるべき多数のピル又は錠剤を含有する ことから成り、該多数のピル又は錠剤が抗黄体ホルモンを含有することから成る 活性薬物を含有する1個のピル又は錠剤を除いて姑息薬であるキット。 20.少なくとも28のピル又は錠剤を含有することから成り、上記活性薬物 を含有するピル又は錠剤を28日めに投与する、請求の範囲第19項記載のキッ ト。 21.少なくとも30のピル又は錠剤を含有することから成り、上記活性薬物 を含有するピル又は錠剤を30日めに投与する、請求の範囲第19項記載のキッ ト。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1992/003574 WO1993021926A1 (en) | 1992-05-06 | 1992-05-06 | Minimizing progestin associated breakthrough bleeding |
WO92/03574 | 1992-05-06 | ||
PCT/US1993/004003 WO1993021927A1 (en) | 1992-05-06 | 1993-05-03 | Minimizing progestin associated breakthrough bleeding |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH08509456A true JPH08509456A (ja) | 1996-10-08 |
JP3937240B2 JP3937240B2 (ja) | 2007-06-27 |
Family
ID=22231028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51949093A Expired - Fee Related JP3937240B2 (ja) | 1992-05-06 | 1993-05-03 | 黄体ホルモン関連の破綻出血の最小化 |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0646008B1 (ja) |
JP (1) | JP3937240B2 (ja) |
KR (1) | KR950700745A (ja) |
CN (1) | CN1073422C (ja) |
AT (1) | ATE187644T1 (ja) |
AU (2) | AU1918092A (ja) |
CA (1) | CA2131911C (ja) |
DE (1) | DE69327319T2 (ja) |
DK (1) | DK0646008T3 (ja) |
ES (1) | ES2142345T3 (ja) |
FI (1) | FI945207A (ja) |
GR (1) | GR3032797T3 (ja) |
NO (1) | NO308581B1 (ja) |
NZ (1) | NZ253405A (ja) |
PT (1) | PT646008E (ja) |
WO (2) | WO1993021926A1 (ja) |
ZA (1) | ZA933153B (ja) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX9301121A (es) | 1992-03-02 | 1993-09-01 | Schering Ag | Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina. |
US7704983B1 (en) | 1992-03-02 | 2010-04-27 | Eastern Virginia Medical School | Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception |
US5439913A (en) | 1992-05-12 | 1995-08-08 | Schering Aktiengesellschaft | Contraception method using competitive progesterone antagonists and novel compounds useful therein |
DE4344463A1 (de) * | 1993-12-22 | 1995-06-29 | Schering Ag | Kombinationsprodukt zur Kontrazeption |
DE69532894T2 (de) * | 1994-11-22 | 2004-09-02 | Balance Pharmaceuticals, Inc., Pacific Palisades | Verfahren zur empfängnisverhütung |
US5521166A (en) * | 1994-12-19 | 1996-05-28 | Ortho Pharmaceitical Corporation | Antiprogestin cyclophasic hormonal regimen |
WO1996023503A1 (de) * | 1995-02-02 | 1996-08-08 | Schering Aktiengesellschaft | Progesteronantagonisten für die herstellung von arzneimitteln zur behandlung von dysfunktionellen uterinen blutungen |
JP2000514785A (ja) * | 1996-06-25 | 2000-11-07 | アクゾ・ノベル・エヌ・ベー | プロゲストゲン―抗プロゲストゲン処方 |
US6506390B2 (en) | 1996-06-25 | 2003-01-14 | Akzo Nobel | Progestogen-anti-progestogen regimens |
BR9814136A (pt) * | 1997-11-14 | 2000-10-03 | Akzo Nobel Nv | Conjunto contraceptivo, processos de fabricação do mesmo e de tratamento de sangramento, usos de anti-progestogênio, de progestogênio e de anti-progestogênio, e, de um composto. |
US6020328A (en) * | 1998-03-06 | 2000-02-01 | Research Triangle Institute | 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
US5962444A (en) * | 1998-05-29 | 1999-10-05 | Research Triangle Institute | 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
US6262042B1 (en) | 1998-05-29 | 2001-07-17 | Research Triangle Institute | 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
SK15502001A3 (sk) * | 1999-04-29 | 2002-03-05 | Akzo Nobel N. V. | Použitie Org 33245 |
US8193252B1 (en) | 1999-08-31 | 2012-06-05 | Bayer Pharma AG | Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders |
US7629334B1 (en) | 1999-08-31 | 2009-12-08 | Bayer Schering Pharma Aktiengesellschaft | Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT) |
GB0010683D0 (en) * | 2000-05-03 | 2000-06-28 | Univ Bristol | Cancer therapy |
DE102007049630A1 (de) | 2007-10-11 | 2009-10-29 | Bayer Schering Pharma Aktiengesellschaft | Nichtsteroidale Progesteronrezeptor-Modulatoren |
DE102007023614A1 (de) | 2007-05-21 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Nichtsteroidale Progesteronrezeptor-Modulatoren |
DE102007032800A1 (de) | 2007-07-10 | 2009-01-15 | Bayer Schering Pharma Aktiengesellschaft | Nichtsteroidale Progesteronrezeptor-Modulatoren |
DE102007058747A1 (de) | 2007-12-05 | 2009-06-10 | Bayer Schering Pharma Aktiengesellschaft | Nichtsteroidale Progesteronrezeptor-Modulatoren |
EP2070909A1 (de) | 2007-12-15 | 2009-06-17 | Bayer Schering Pharma AG | Nichtsteroidale Progesteronrezeptor-Modulatoren |
EP2123279A1 (de) * | 2008-05-14 | 2009-11-25 | Bayer Schering Pharma Aktiengesellschaft | Sequentielle Verabreichung von 20,20,21,21,21-Pentafluor-17-hydroxy-1 1beta-[4-(hydroxyacetyl) phenyl]-19-nor-17alpha-pregna-4,9-dien-3-on und einem oder mehreren Gestagenen zur Behandlung gynäkologischer Erkrankungen |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA935617B (en) * | 1992-08-14 | 1994-03-07 | Akzo Nv | Antiprogestogen containing contraceptives. |
-
1992
- 1992-05-06 AU AU19180/92A patent/AU1918092A/en not_active Abandoned
- 1992-05-06 WO PCT/US1992/003574 patent/WO1993021926A1/en active Application Filing
-
1993
- 1993-05-03 DK DK93913781T patent/DK0646008T3/da active
- 1993-05-03 EP EP93913781A patent/EP0646008B1/en not_active Expired - Lifetime
- 1993-05-03 JP JP51949093A patent/JP3937240B2/ja not_active Expired - Fee Related
- 1993-05-03 NZ NZ253405A patent/NZ253405A/en not_active IP Right Cessation
- 1993-05-03 WO PCT/US1993/004003 patent/WO1993021927A1/en active IP Right Grant
- 1993-05-03 AT AT93913781T patent/ATE187644T1/de not_active IP Right Cessation
- 1993-05-03 ES ES93913781T patent/ES2142345T3/es not_active Expired - Lifetime
- 1993-05-03 AU AU43685/93A patent/AU667729B2/en not_active Ceased
- 1993-05-03 DE DE69327319T patent/DE69327319T2/de not_active Expired - Fee Related
- 1993-05-03 PT PT93913781T patent/PT646008E/pt unknown
- 1993-05-03 CA CA002131911A patent/CA2131911C/en not_active Expired - Fee Related
- 1993-05-05 ZA ZA933153A patent/ZA933153B/xx unknown
- 1993-05-06 CN CN93105281A patent/CN1073422C/zh not_active Expired - Fee Related
-
1994
- 1994-09-30 KR KR1019940703439A patent/KR950700745A/ko not_active IP Right Cessation
- 1994-11-04 NO NO944210A patent/NO308581B1/no not_active IP Right Cessation
- 1994-11-04 FI FI945207A patent/FI945207A/fi not_active Application Discontinuation
-
2000
- 2000-02-29 GR GR20000400498T patent/GR3032797T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0646008B1 (en) | 1999-12-15 |
FI945207A0 (fi) | 1994-11-04 |
DE69327319D1 (de) | 2000-01-20 |
CA2131911A1 (en) | 1993-11-11 |
FI945207A (fi) | 1994-11-04 |
NO308581B1 (no) | 2000-10-02 |
NZ253405A (en) | 1997-06-24 |
AU1918092A (en) | 1993-11-29 |
PT646008E (pt) | 2000-04-28 |
EP0646008A1 (en) | 1995-04-05 |
AU4368593A (en) | 1993-11-29 |
ZA933153B (en) | 1993-12-06 |
GR3032797T3 (en) | 2000-06-30 |
KR950700745A (ko) | 1995-02-20 |
NO944210D0 (no) | 1994-11-04 |
CN1073422C (zh) | 2001-10-24 |
WO1993021926A1 (en) | 1993-11-11 |
AU667729B2 (en) | 1996-04-04 |
CN1079651A (zh) | 1993-12-22 |
JP3937240B2 (ja) | 2007-06-27 |
CA2131911C (en) | 2005-12-27 |
DK0646008T3 (da) | 2000-05-15 |
WO1993021927A1 (en) | 1993-11-11 |
DE69327319T2 (de) | 2000-07-13 |
EP0646008A4 (en) | 1995-10-11 |
NO944210L (no) | 1994-11-04 |
ES2142345T3 (es) | 2000-04-16 |
ATE187644T1 (de) | 2000-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3937240B2 (ja) | 黄体ホルモン関連の破綻出血の最小化 | |
EP0686037B1 (en) | Hormone replacement therapy | |
US4855305A (en) | Compositions and methods of effecting contraception utilizing melatonin | |
EP0799043B1 (en) | Cyclophasic hormonal regimen containing antiprogestin and progestin | |
RU2189819C2 (ru) | Схемы приема прогестогена-антипрогестогена | |
CZ195397A3 (en) | Progesteron antagonistically and antiestrogenic active compounds for common use for woman contraception | |
US5468741A (en) | Use of low levels of mifepristone to treat leiomyomata | |
JPH11511157A (ja) | 避妊用複合調剤、複合調剤を含有するキット及び複合調剤の使用方法 | |
JP2003048836A (ja) | 効能を保持し無月経を引き起こす超低用量の経口避妊薬 | |
US5622943A (en) | Minimizing progestin associated breakthrough bleeding | |
US6642219B1 (en) | Progestogen-antiprogestogen regimens | |
JP2003511399A (ja) | 女性避妊薬の成分としてのメソプロゲスチン(プロゲステロン受容体モジュレーター) | |
Baulieu | A novel approach to human fertility control: contragestion by the anti-progesterone RU 486 | |
FI114687B (fi) | Kitti hedelmöitymisen ehkäisemiseksi | |
JP2001513566A (ja) | 経口避妊における、エストロゲンと子宮内膜節約性プロゲスチンおよび子宮内膜萎縮性プロゲスチンとの組み合わせ物 | |
US11376263B2 (en) | Cyproterone acetate compositions and uses thereof | |
NZ233697A (en) | Contraceptive composition comprising a melatonin analogue and a progestogen and/or an estrogen | |
AU644367B2 (en) | Use of melatonin derivatives for effecting contraception | |
JPS63316725A (ja) | プロゲステロン合成阻害剤及び抗ゲスタゲンを含有する医薬及びその製法 | |
IL94411A (en) | Compositions comprising an analog of melatonin in combination with progestogen and/or estrogen for effecting contraception | |
JP2007197459A (ja) | 月経の出血を少なくし維持された効力を持つ超低投与量避妊薬 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20040115 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20040301 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040415 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20050607 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20051130 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20051130 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070206 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070315 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |